Stagwell (STGW) Chairman and CEO Mark Penn Releases Statement on Roe v. Wade
NEW YORK, June 24, 2022 /PRNewswire/ -- Stagwell Chairman and CEO Mark Penn released a statement today in response to the Supreme Court's decision to overturn Roe v. Wade.
"We are singularly focused on supporting our people through this transition. While we cannot predict how abortion access will evolve in the coming months, or even years, Stagwell believes employees should have access to excellent health care, regardless of their location. We are taking immediate steps that will expand our network travel benefits to give employees access to the nearest approved reproductive healthcare provider in a legally permissible way," said Penn. "We hope this travel benefit will provide employees located in states that have implemented new restrictions on reproductive rights with access to care."
About Stagwell
Stagwell is the challenger network built to transform marketing. We deliver scaled creative performance for the world's most ambitious brands, connecting culture-moving creativity with leading-edge technology to harmonize the art and science of marketing. Led by entrepreneurs, our 12,000+ specialists in 34+ countries are unified under a single purpose: to drive effectiveness and improve business results for their clients. Join us at www.stagwellglobal.com.
Neurogene Inc. , a clinical-stage company founded to bring life-changing genetic medicines to patients and families affected by rare neurological diseases, today announced first quarter 2024 financial results and highlighted recent corporate updates....
The judgment in Bennett, et. al v. Providence Health & Services, was entered in King County Superior Court yesterday, the culmination of a two-week trial which took place late last month. Providence is ordered to pay more than 33,000 of its hourly...
Soligenix, Inc. (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced today its recent accomplishments and...
Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company") , Canada's largest and one of North America's fastest growing networks of dental practices, today announced its financial and operating results for the first quarter ended March 31, 2024. All...
Castle Biosciences, Inc. , a company improving health through innovative tests that guide patient care, today announced that it has been selected as the winner of the "Best Overall Mental Health Solution" award in the eighth annual MedTech...
REGENXBIO Inc. today announced it will participate in the following upcoming investor conferences:
BofA Securities Health Care Conference 2024Fireside Chat: Wednesday, May 15, 2024 at 2:20 p.m. ETLocation: Las Vegas, NV
Stifel 2024 Tailoring Genes...
